Galectin Therapeutics Inc.
NASDAQ:GALT
1.15 (USD) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.033 | 0.032 | 0.041 | 0.036 | 0.035 | 0 | 0.001 | 0.007 | 0.007 | 0 | 0 | 0 | 0 | 0 | 0 | 5.326 | 6.455 | 7.048 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.033 | -0.032 | -0.041 | -0.036 | -0.035 | 0 | -0.001 | -0.007 | -0.007 | 0 | 0 | 0 | 0 | 0 | 0 | -5.326 | -6.455 | -7.048 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 32.13 | 31.737 | 23.818 | 17.976 | 7.467 | 6.471 | 11.721 | 15.325 | 13.114 | 8.425 | 5.688 | 4.527 | 3.552 | 1.066 | 1.11 | 1.774 | 2.053 | 3.019 | 3.04 | 3.042 | 1.95 | 1.483 | 0.893 | 0.1 |
| General & Administrative Expenses
| 5.898 | 6.615 | 6.361 | 5.468 | 5.971 | 7.131 | 4.526 | 6.156 | 6.965 | 7.005 | 6.416 | 5.372 | 6.857 | 3.817 | 4.983 | 3.552 | 4.402 | 4.029 | 3.615 | 4.262 | 2.988 | 1.804 | 1.289 | 0.07 |
| Selling & Marketing Expenses
| 0.044 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 5.942 | 6.615 | 6.361 | 5.468 | 5.971 | 7.131 | 4.526 | 6.156 | 6.965 | 7.005 | 6.416 | 5.372 | 6.857 | 3.817 | 4.983 | 3.552 | 4.402 | 4.029 | 3.615 | 4.262 | 2.988 | 1.804 | 1.289 | 0.07 |
| Other Expenses
| -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 38.072 | 38.352 | 30.179 | 23.444 | 13.438 | 13.602 | 16.247 | 21.481 | 20.079 | 15.43 | 12.104 | 9.899 | 10.409 | 4.883 | 6.093 | 5.326 | 6.455 | 7.048 | 6.655 | 7.304 | 4.938 | 3.287 | 2.182 | 0.17 |
| Operating Income
| -38.072 | -38.352 | -30.179 | -23.444 | -13.438 | -13.602 | -16.247 | -21.481 | -20.079 | -15.43 | -12.104 | -9.899 | -10.409 | -4.883 | -6.093 | -5.326 | -6.455 | -7.048 | -6.655 | -7.304 | -4.938 | -3.287 | -2.182 | -0.17 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -2.994 | -0.424 | -0.348 | -0.021 | 0.144 | -0.298 | 0.012 | 0.045 | 0.052 | -0.358 | 0.016 | 0.224 | -0.506 | -0.746 | -1.369 | 2.175 | -2.978 | 3.855 | 0.111 | 0.124 | 0.065 | -0.391 | 0 | -0.02 |
| Income Before Tax
| -41.066 | -38.776 | -30.527 | -23.465 | -13.294 | -13.9 | -16.235 | -21.436 | -20.027 | -15.788 | -12.088 | -9.675 | -10.915 | -5.629 | -7.462 | -3.151 | -9.433 | -3.193 | -6.544 | -7.18 | -4.873 | -3.678 | 0 | -0.19 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0.424 | 0.448 | 0.051 | 0.087 | -0.123 | 0.024 | 0 | 0 | -0.052 | 0.016 | 0.2 | 0.506 | 0.746 | 1.369 | -2.175 | 2.978 | -3.855 | 0 | 0 | 0 | 0 | 1.788 | 0 |
| Net Income
| -41.066 | -39.2 | -30.975 | -23.516 | -13.381 | -13.9 | -16.235 | -21.436 | -20.027 | -15.788 | -12.088 | -9.675 | -10.915 | -5.629 | -7.462 | -3.151 | -9.433 | -3.193 | -6.544 | -7.18 | -4.873 | -3.678 | -3.97 | -0.19 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.74 | -0.66 | -0.53 | -0.41 | -0.26 | -0.35 | -0.46 | -0.73 | -0.83 | -0.72 | -0.72 | -0.64 | -0.91 | -0.6 | -0.93 | -0.4 | -1.45 | -0.67 | -1.44 | -1.67 | -1.37 | -1.35 | -1.75 | -0.092 |
| EPS Diluted
| -0.74 | -0.66 | -0.53 | -0.41 | -0.26 | -0.35 | -0.46 | -0.73 | -0.83 | -0.72 | -0.72 | -0.64 | -0.91 | -0.6 | -0.93 | -0.4 | -1.45 | -0.67 | -1.44 | -1.67 | -1.37 | -1.35 | -1.75 | -0.092 |
| EBITDA
| -0.202 | -37.711 | -29.997 | -23.342 | -13.172 | -13.564 | -16.234 | -21.474 | -20.071 | -15.778 | -12.076 | -9.666 | -10.906 | -5.617 | -7.425 | -3.102 | -9.019 | -1.276 | -6.773 | -7.099 | -4.849 | -3.076 | -2.023 | -0.19 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |